China Care Atlas logo
China Care Atlas
  • Home
  • Hospitals
  • Treatments
  • Build My Plan
  • Guides
China Care Atlas logo
China Care Atlas

Compare top hospitals, advanced treatments, and transparent medical tourism information for China before you book travel.

Quick Links
HospitalsTreatmentsBuild My PlanGuides
Advanced Treatments
CAR-T & Cell TherapyProton & Heavy IonCardiovascular SurgeryComplex Neurosurgery
Legal
AboutContactHow We ResearchPrivacy PolicyTerms

2026 China Care Atlas. Advanced, Transparent Healthcare in China.

Hospital specialists reviewing a treatment plan in China
SPECIALTY & TREATMENT DIRECTORY

Specialties & Treatments in China

45Fudan specialty rankings loaded5Major Treatment Directions26Treatment pathways reviewedEditorial research desk · independent

Research-stage dataset · status research only · intake details needs direct confirmation · directions reviewed 18 August 2026. Not a clinical recommendation; confirm eligibility and access directly with the hospital.

Popular:
Research-stage hospital & therapy matrix

Advanced Treatment Pathways & Hospital Centers

Research notes on Chinese tertiary centers, advanced modalities (CAR-T, particle therapy, robotic surgery, organ transplant), target indications, and international patient access routes. Capability notes are starting points for direct confirmation, not a referral or acceptance decision.

Dataset status research only·intake release needs direct confirmation·reviewed 18 August 2026

Clinical Desk 02复杂或复发肿瘤Research review · needs direct confirmation

Complex or recurrent cancers

Specialized particle radiotherapy (carbon-ion & proton), high-complexity salvage surgery, and indication-specific immunotherapy for recurrent, refractory, or unresectable solid tumors.

Explore Full Guide & Hospitals

Leading Hospital Centers & Specific Treatments Offered

Research notes on Chinese tertiary hospitals, specific advanced modalities, target indications, and international patient pathways

2 hospitals profiled
Directory cross-check0 of 3 candidates in our hospital directory3 not yet listed
  • Shanghai Proton and Heavy Ion Centernot in our hospital directory
  • Fudan University Shanghai Cancer Centernot in our hospital directory
  • Ruijin Hospitalnot in our hospital directory

A missing entry means our hospital directory does not cover that facility yet; it is not a statement about the facility's clinical capability.

Shanghai Proton and Heavy Ion Center (上海市质子重离子医院)
ShanghaiGrade 3A Specialized · International Particle Radiotherapy Center
Capability noted in research
Specific Advanced Treatments & Technologies Offered:
Particle RadiotherapyLeading Center Technique
Carbon-Ion Precise Particle Therapy (碳离子重离子精准放疗)
Target Indication:

Recurrent nasopharyngeal carcinoma, skull-base chordoma, localized prostate cancer, soft tissue sarcomas

Clinical Feature: High linear energy transfer (LET) heavy particles with sharp Bragg peak; superior cell-killing effect on hypoxic radioresistant tumors.

Particle RadiotherapyRoutine Clinical Center
Proton Beam Pencil-Scanning Radiotherapy (质子笔形束扫描放疗)
Target Indication:

Pediatric CNS tumors, chordomas, head-and-neck malignancies adjacent to critical neural pathways

Clinical Feature: Zero exit-dose sparing surrounding normal tissue, preserving cognitive and endocrine functions in adjacent structures.

International Patient Access:

Official English consultation channel (sphicvip@sphic.org.cn) supporting remote DICOM image prescreening and itemized particle therapy quotes.

Pre-Travel Candidacy Note:

Active international intake. Requires pre-arrival submission of all previous photon radiation dose distribution plans and contrast MRI/PET-CT.

Fudan University Shanghai Cancer Center (复旦大学附属肿瘤医院)
ShanghaiGrade 3A Public · National Cancer Medical Center
Capability noted in research
Specific Advanced Treatments & Technologies Offered:
Complex Surgery & TransplantNational Reference Center
Complex Head & Neck Endoscopic Skull-Base Surgery
Target Indication:

Locally recurrent nasopharyngeal carcinoma, sinus malignancies, salivary-gland cancers

Clinical Feature: Intraoperative robotic navigation, high-definition endoscope, carotid artery balloon occlusion assessment.

Complex Surgery & TransplantLeading Center Technique
Da Vinci Xi Robotic Radical Pelvic and Retroperitoneal Dissection
Target Indication:

Recurrent pelvic tumors, retroperitoneal liposarcomas, complex colorectal recurrences

Clinical Feature: High-precision nerve-sparing microdissection with multi-organ en-bloc resections.

International Patient Access:

International Medical Department coordinates English record intake, MDT panel review, and priority hospital admission.

Pre-Travel Candidacy Note:

Direct medical intake for international complex-surgery candidates. High surgical complexity threshold.

Cross-Specialty Collaboration Route:
Primary: OncologyGeneral surgeryRadiologyPathologyNuclear medicineThoracic surgery

Target Disease Indications & Qualified Hospital Finder (5)

Which Chinese tertiary hospitals are noted for the beds, ICU support, and technologies each condition typically needs

5 target conditions
High-Priority Target#01
Locally Recurrent Nasopharyngeal Carcinoma (NPC) & Skull Base Tumors (复发鼻咽癌与颅底脊索瘤)

Target Stage & Goal: Local recurrence of nasopharyngeal carcinoma after prior radical photon radiotherapy, or unresectable skull-base chordoma/chondrosarcoma adjacent to critical neurovascular structures.

Hospitals noted for treating this condition (confirm eligibility directly):
Shanghai Proton and Heavy Ion Center (SPHIC / 上海市质子重离子医院)
Shanghai · Premier Carbon-Ion & Proton Radiotherapy Facility
Head & Neck Radiation Oncology / International Medical Service
Hospital Facilities & Qualified Conditions:

Siemens synchrotron particle accelerator delivering carbon ions and protons, sub-millimeter 3D pencil-beam scanning, 6-degree-of-freedom robotic treatment couches, real-time 4D CT motion tracking.

Specific Treatment & Technology Offered:

Carbon-Ion Re-Irradiation (高相对生物有效性碳离子线二次放疗,精准破坏癌细胞双链DNA且周围危及器官受量急剧下降).

Required Patient Eligibility Criteria:

Confirmed localized recurrence or unresectable skull base tumor; interval from previous radiation >1 year; tumor distance to brainstem/optic chiasm >3 mm; KPS performance score ≥70; no distant metastases.

Fudan University Shanghai Cancer Center (FUSCC / 复旦大学附属肿瘤医院)
Shanghai · National Cancer Clinical Medical Center
Department of Head & Neck Surgery / MDT Center
Hospital Facilities & Qualified Conditions:

World-renowned head and neck surgical oncology division, high-definition endoscopic skull base surgery theater, multi-modality tumor board.

Specific Treatment & Technology Offered:

Transnasal Endoscopic Skull Base Salvage Resection + Intraoperative Navigation.

Required Patient Eligibility Criteria:

Resectable recurrence without circumferential internal carotid artery encasement; patient able to tolerate general endotracheal anesthesia.

High-Priority Target#02
Locally Advanced / Unresectable Hepatocellular Carcinoma (局部晚期原发性肝癌)

Target Stage & Goal: Large solitary or multi-nodular hepatocellular carcinoma not amenable to curative open resection due to insufficient future liver remnant or microvascular invasion.

Hospitals noted for treating this condition (confirm eligibility directly):
Shanghai Proton and Heavy Ion Center (SPHIC)
Shanghai · Particle Radiotherapy Benchmark
Abdominal Radiation Oncology Division
Hospital Facilities & Qualified Conditions:

Advanced respiratory gating system, implanted gold fiducial marker tracking, non-invasive stereotactic body immobilization.

Specific Treatment & Technology Offered:

Hypofractionated Carbon-Ion Radiotherapy (大分割碳离子放疗,通常仅需4-10次照射即可彻底消融大体积肝肿瘤).

Required Patient Eligibility Criteria:

Child-Pugh class A or well-compensated B (score ≤7); residual non-tumorous liver volume >30%; tumor diameter ≤15 cm; absence of macro-vascular portal vein main trunk occlusion and distant metastases.

Zhongshan Hospital, Fudan University (复旦大学附属中山医院)
Shanghai · National Medical Center (Liver Cancer Institute)
Liver Cancer Institute / International Medical Center
Hospital Facilities & Qualified Conditions:

World's highest-volume robotic liver resection suites, integrated microvascular interventional catheterization labs (TACE / HAIC), liver transplantation ICU.

Specific Treatment & Technology Offered:

Hepatic Arterial Infusion Chemotherapy (HAIC-FOLFOX) downstaging combined with Da Vinci Xi robotic radical liver resection.

Required Patient Eligibility Criteria:

BCLC stage B/C liver cancer with good hepatic reserve (ICG-15 <15%); ECOG score 0-1.

High-Priority Target#03
Locally Advanced Pancreatic Adenocarcinoma (局部晚期胰腺癌)

Target Stage & Goal: Borderline resectable or locally advanced pancreatic cancer with celiac axis or superior mesenteric artery/vein encasement without distant metastases.

Hospitals noted for treating this condition (confirm eligibility directly):
Fudan University Shanghai Cancer Center (FUSCC) & SPHIC
Shanghai · National Cancer Clinical Center & Particle Center
Department of Pancreatic Surgery / Multidisciplinary Oncology Clinic
Hospital Facilities & Qualified Conditions:

Specialized Pancreatic Cancer Institute, vascular reconstruction surgical theater, carbon-ion beam planning avoiding adjacent duodenal mucosa.

Specific Treatment & Technology Offered:

Neoadjuvant Carbon-Ion Radiation / Systemic Chemotherapy followed by Radical Pancreaticoduodenectomy (Whipple) with Mesenteric Vessel Reconstruction.

Required Patient Eligibility Criteria:

Pathologically confirmed adenocarcinoma; vascular contact without distant peritoneal seeding; CA19-9 verifiable; KPS score ≥80.

Specialized Indication#04
Recurrent High-Grade Glioma & Deep Brain Tumors (难治复发胶质母细胞瘤与颅内深部肿瘤)

Target Stage & Goal: Recurrent glioblastoma or refractory deep brain tumor after standard temozolomide chemoradiation requiring precision re-intervention.

Hospitals noted for treating this condition (confirm eligibility directly):
Beijing Tiantan Hospital & SPHIC
Beijing / Shanghai · National Neurological Center & Particle Facility
Glioma Center / International Medical Center
Hospital Facilities & Qualified Conditions:

Neurosurgical theaters equipped with intraoperative 3.0T MRI, 5-ALA fluorescence tumor visualization, neuronavigation, proton pencil beam scanning.

Specific Treatment & Technology Offered:

Fluorescence-Guided Maximum Safe Microsurgical Resection + Postoperative Focused Carbon-Ion/Proton Particle Boost.

Required Patient Eligibility Criteria:

Histologically verified recurrent high-grade glioma (WHO grade 3-4); KPS ≥60; localized recurrence with clear surgical or particle radiotherapy margins.

Specialized Indication#05
Gastrointestinal & Colorectal Peritoneal Carcinomatosis (晚期结直肠癌/胃癌腹膜转移)

Target Stage & Goal: Peritoneal surface dissemination from colorectal or gastric cancer with controlled systemic disease and low-to-moderate tumor burden.

Hospitals noted for treating this condition (confirm eligibility directly):
Fudan University Shanghai Cancer Center & Ruijin Hospital
Shanghai · Grade 3A Public (National Cancer Clinical Centers)
Colorectal & Peritoneal Oncology Team
Hospital Facilities & Qualified Conditions:

Specialized hyperthermic intraperitoneal chemotherapy (HIPEC) closed-loop perfusion machines, 4K 3D laparoscopic surgical theaters.

Specific Treatment & Technology Offered:

Cytoreductive Surgery (CRS) + Continuous Hyperthermic Intraperitoneal Chemotherapy (HIPEC) + Targeted Molecular Therapy.

Required Patient Eligibility Criteria:

Peritoneal Cancer Index (PCI) score ≤20; complete cytoreduction achievable (CC-0/1); no extra-abdominal metastases; ECOG 0-1.

Records Needed Before Clinical Review (5)

  • ✓Complete radiation treatment plan reports: Total Gy, fractionation schedule, beam angles, and original DICOM RT dose files
  • ✓All previous surgical pathology reports, immunohistochemistry (IHC) slides, and molecular genomic testing
  • ✓Recent high-resolution contrast-enhanced MRI and PET-CT scans performed within 3 weeks (DICOM format)
  • ✓Documentation of performance status (KPS / ECOG) and neurological deficit exam
  • ✓Endoscopic reports and photos for head & neck or gastrointestinal lesions

Practical Pathway Financial Scope (4 stages)

Where expenses occur across the pathway · figures are published reference ranges
Stage 1: Remote Diagnostic Prescreening & MDT Feasibility (远程度预审与MDT)

Scope: Expert radiation oncologist and surgeon review of previous RT dose distributions, DICOM scans, and eligibility confirmation.

Financial Notes: Consultation fee usually paid prior to formal admission; establishes whether carbon-ion or surgery is clinically viable.

Stage 2: Particle Simulation, 4D Motion Modeling & Planning (放疗模拟定位与排布)

Scope: Custom thermoplastic immobilization mask/mold, 4D respiratory-correlated CT, contrast MRI fusion, and physicist beam planning.

Financial Notes: Essential preparatory phase requiring 5-7 days before beam delivery starts.

Stage 3: Carbon-Ion / Proton Treatment Delivery (重离子/质子照射实施)

Scope: Standard course of carbon-ion therapy (typically 12 to 24 fractions) or combined proton boost in specialized treatment gantry.

Financial Notes: SPHIC published standard particle radiotherapy course package is approximately 278,000 - 310,000 RMB for direct radiation.

Published reference range · noted 2026-08-18 · confirm current price

Stage 4: Inpatient Supportive Care & Post-Radiation Review (住院支持与出院评估)

Scope: Inpatient room charges, mucosal protection, nutritional support, post-treatment verification MRI, and international follow-up schedule.

Financial Notes: Outpatient or inpatient accommodations around the center; total pathway budget should include 30-45 days local stay.

Published reference ranges noted 2026-08-18; they are not a quote. Confirm the current itemized price and payment terms directly with the hospital before budgeting or travel.

Budgeting & Cost Scope Notice:

The fixed particle therapy package does not include preoperative systemic chemotherapy, special custom stents, complex vascular reconstruction, or extended ICU stays.

Published intake contacts — confirm before use
needs direct confirmation

No published international contact is recorded for this desk. Ask the candidate hospital's VIP or international center case by case.

Pre-Travel Clinical Intake Advisory

Pre-arrival record review, prior-radiation constraints, exclusion criteria, wait time, and itemized international-patient quote

Advanced Clinical Research

Priority Treatment Directions

Dedicated clinical desks for complex, refractory, and rare conditions in China.

Desk 01血液肿瘤与细胞治疗

Hematologic cancers & cell therapy

Blood cancers, transplantation, and indication-specific cell therapies.

Priority Pathways

Relapsed or refractory multiple myelomaRelapsed or refractory large B-cell lymphomaAcute lymphoblastic leukemia

Key Centers

  • Ruijin Hospitalnot in our hospital directory
  • Shanghai SinoUnited Hospitalnot in our hospital directory
Explore Research Desk
Desk 02复杂或复发肿瘤

Complex or recurrent cancers

Multidisciplinary options for recurrent, refractory, or technically difficult tumors.

Priority Pathways

Recurrent nasopharyngeal and complex head-and-neck cancersRefractory or recurrent brain tumorsAdvanced CLDN18.2-positive gastric or gastroesophageal junction cancer

Key Centers

  • Shanghai Proton and Heavy Ion Centernot in our hospital directory
  • Fudan University Shanghai Cancer Centernot in our hospital directory
Explore Research Desk
Desk 03儿童复杂与罕见病

Pediatric complex & rare diseases

Specialist children’s hospitals for oncology, congenital disease, and rare-disease review.

Priority Pathways

Pediatric leukemia, lymphoma, and solid tumorsComplex congenital heart diseaseGenetic, metabolic, and undiagnosed rare diseases

Key Centers

  • Shanghai Children's Medical Centernot in our hospital directory
  • Children's Hospital of Fudan Universitynot in our hospital directory
Explore Research Desk
Desk 04复杂神经疾病

Complex neurological diseases

Neurosurgery, epilepsy, movement disorders, and coordinated rehabilitation.

Priority Pathways

Complex brain tumorsCerebrovascular malformations and complex cerebrovascular diseaseDrug-resistant epilepsy

Key Centers

  • Beijing Tiantan Hospitalnot in our hospital directory
  • Huashan Hospitalnot in our hospital directory
Explore Research Desk
Desk 05复杂心血管疾病

Complex cardiovascular diseases

Aortic, structural, congenital, and inherited heart-disease programs.

Priority Pathways

Aortic dissection and complex aortic diseaseAdult complex congenital heart diseasePediatric complex congenital heart disease

Key Centers

  • Fuwai Hospitalnot in our hospital directory
  • Shanghai Children's Medical Centernot in our hospital directory
Explore Research Desk

How to use this directory

Rankings as a Starting Guide

Use rankings to shortlist top departments, then verify international access and care fit.

  1. 01

    Choose the specialty first

    Start with the department that treats your condition, not the best-known hospital name.

  2. 02

    Align department strengths with access

    Review specialized clinical teams, English medical services, and admission channels alongside hospital reputation.

  3. 03

    Prepare structured clinical documentation

    Compile standardized diagnostic summaries, scans, and clinical histories to facilitate direct hospital evaluation.

Continue with a specific case

Build Your Care Pathway

Organize medical records, confirm hospital fit, and plan next steps before traveling.

Build a personalized care plan

1. Confirm the department route

Check that the named department, not only the hospital, can review the condition you are researching.

2. Prepare a usable record set

Bring translated summaries, imaging, pathology, treatment history, and a concise clinical question.

3. Confirm access before travel

Ask the hospital about appointment timing, record submission, language support, payment, and follow-up needs.

Next step

Choose your next step

Explore accredited public hospitals with dedicated international patient departments, or generate an individualized travel plan.

Explore Top HospitalsBuild My Plan